Colchicintherapie nach MyokardinfarktColchicine Cardiovascular Outcomes Trial (COLCOT)Colchicine treatment after myocardial infarctionColchicine Cardiovascular Outcomes Trial (COLCOT)

被引：0
|
作者：
R. Klingenberg
S. Nitschmann
机构：
[1] Campus Kerckhoff der Justus-Liebig-Universität Gießen,Abteilung Kardiologie, Kerckhoff
来源：
Der Internist | 2020年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：766 / 769
页数：3
相关论文
共 50 条
  • [31] Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial
    Abdalrhim, Ahmed D.
    Marroush, Tariq S.
    Austin, Erin E.
    Gersh, Bernard J.
    Solak, Nusret
    Rizvi, Syed A.
    Bailey, Kent R.
    Kullo, Iftikhar J.
    PLOS ONE, 2016, 11 (06):
  • [32] Interrelationship between hypoglycaemia and cardiovascular and mortality outcomes in the CAROLINA trial
    Marx, N.
    Rosenstock, J.
    McGuire, D. K.
    Zinman, B.
    Espeland, M. A.
    George, J. T.
    Mattheus, M.
    Johansen, O. E.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S284 - S284
  • [33] Rosiglitazone Evaluated for Cardiovascular Outcomes: An Interim Analysis of the RECORD Trial
    Kurukulasuriya, L. Romayne
    McFarlane, Samy I.
    CURRENT CARDIOVASCULAR RISK REPORTS, 2008, 2 (02) : 85 - 87
  • [34] Effect of liraglutide on cardiovascular outcomes in elderly patients in the LEADER trial
    Gilbert, M. P.
    Bain, S. C.
    Franek, E.
    Jodar-Gimeno, E.
    Nauck, M. A.
    Pratley, R. E.
    Rea, R.
    Saraiva, J.
    Rasmussen, S.
    Tornoe, K.
    von Scholten, B.
    Buse, J.
    DIABETOLOGIA, 2018, 61 : S368 - S369
  • [35] Time to Insulin in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
    Bethel, M. A.
    Engel, Samuel S.
    Garg, Jyotsna
    Stevens, Susanna R.
    Lokhnygina, Yuliya
    Josse, Robert G.
    Green, Jennifer B.
    Peterson, Eric D.
    Holman, Rury R.
    DIABETES, 2017, 66 : A316 - A316
  • [36] Rationale and design of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)
    Bethel, M. A.
    Green, J.
    Califf, R. M.
    Holman, R. R.
    DIABETOLOGIA, 2009, 52 : S480 - S480
  • [37] Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial
    Qamar, Arman
    Giugliano, Robert P.
    Bohula, Erin A.
    Park, Jeong-Gun
    Jarolim, Petr
    Murphy, Sabina A.
    Blazing, Michael A.
    Califf, Robert M.
    Cannon, Christopher P.
    Braunwald, Eugene
    Morrow, David A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (08) : 1057 - 1068
  • [38] Cognitive and cardiovascular outcomes in the scope anti-hypertensive trial
    Hofman, A
    Skoog, I
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 229 : 371 - 371
  • [39] Plasma Triglyceride Reduction and Cardiovascular Risk in ODYSSEY Outcomes Trial
    Packard, Chris J.
    Boren, Jan
    Chapman, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (04)
  • [40] EFFECT OF LIRAGLUTIDE ON CARDIOVASCULAR OUTCOMES IN ELDERLY PATIENTS IN THE LEADER TRIAL
    Gilbert, Matthew
    Bain, Stephen
    Franek, Edward
    Jodar-Gimeno, Esteban
    Nauck, Michael
    Pratley, Richard
    Rea, Rosangela
    Saraiva, Jose
    Rasmussen, Soren
    Tornoe, Karen
    von Scholten, Bernt Johan
    Buse, John B.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1718 - 1718
12345